ARTICLES BY ESHAAN JAIN

• Undocumented Changes Break Validated Clinical Systems

  10/5/2026

  Small changes to IRT, EDC, and CTMS systems can quietly break validation. See why change control, testing, and documented approvals matter before deployment in a trial.

• Segregation Of Duties: Drug Accountability Needs Three Separate Roles

  9/28/2026

  When one person orders, receives, and reconciles investigational product, a critical control disappears. See how role separation can strengthen drug accountability.

• Token Costs Will Decide Clinical Supply AI

  9/21/2026

  AI may make clinical supply forecasting faster, but cheaper tokens can drive higher costs. See how to measure AI at scale before a pilot becomes an expensive surprise.

• Clinical Supply Systems Need IT General Controls

  9/14/2026

  Validating a clinical trial system does not prove it stays trustworthy. IT general controls can protect data, supply decisions and patient safety long after go-live.

• Last-Mile Lessons For Depot-To-Site Delivery

  9/7/2026

  Depot-to-site delivery is more than a courier handoff. See how reconciliation gaps, temperature risks, and mismatched SLAs can turn last-mile issues into trial delays.

• Lessons In Forecasting Discipline From A $40B Supply Chain

  8/31/2026

  Forecasting errors rarely start with the algorithm. They start when protocol changes, enrollment and site data reach the supply plan too late to prevent waste and disruption.

• Accountability Gaps Can Break Clinical Supply Contracts

  8/24/2026

  Contract gaps can create clinical supply failures when responsibilities differ across agreements. See how aligning obligations can prevent costly disputes, delays, and risks.

• Fixing The Data Problem Before AI Can Help Clinical Trial Supply

  8/14/2026

  AI cannot fix clinical trial supply forecasting when the underlying data is fragmented. Structuring enrollment, inventory, and label data comes first.